AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 169 filers reported holding AXSOME THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.60 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $771,000 | +694.8% | 7,454 | +55.3% | 0.01% | +400.0% |
| Q3 2019 | $97,000 | -21.8% | 4,800 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $124,000 | +158.3% | 4,800 | +41.2% | 0.00% | – |
| Q1 2019 | $48,000 | +1100.0% | 3,400 | +113.7% | 0.00% | – |
| Q4 2018 | $4,000 | -63.6% | 1,591 | -50.8% | 0.00% | – |
| Q3 2018 | $11,000 | -8.3% | 3,236 | -35.0% | 0.00% | – |
| Q2 2018 | $12,000 | 0.0% | 4,976 | 0.0% | 0.00% | – |
| Q1 2018 | $12,000 | +500.0% | 4,976 | +1172.6% | 0.00% | – |
| Q4 2017 | $2,000 | 0.0% | 391 | 0.0% | 0.00% | – |
| Q3 2017 | $2,000 | 0.0% | 391 | 0.0% | 0.00% | – |
| Q2 2017 | $2,000 | 0.0% | 391 | 0.0% | 0.00% | – |
| Q1 2017 | $2,000 | -33.3% | 391 | 0.0% | 0.00% | – |
| Q4 2016 | $3,000 | 0.0% | 391 | 0.0% | 0.00% | – |
| Q3 2016 | $3,000 | – | 391 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,123,929 | $42,462,000 | 36.04% |
| MORGAN JESS S & CO INC | 114,525 | $4,327,000 | 2.66% |
| Fairmount Funds Management LLC | 187,598 | $7,087,000 | 2.34% |
| WMS Partners, LLC | 242,500 | $9,162,000 | 1.95% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 610,064 | $23,048,000 | 1.41% |
| MANGROVE PARTNERS IM, LLC | 400,000 | $15,112,000 | 0.90% |
| RTW INVESTMENTS, LP | 1,618,819 | $61,159,000 | 0.89% |
| MPM BioImpact LLC | 103,405 | $3,907,000 | 0.71% |
| Avidity Partners Management LP | 775,000 | $29,280,000 | 0.62% |
| FIRST MIDWEST BANK TRUST DIVISION | 115,028 | $4,346,000 | 0.56% |